Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 197 of 5804
-
New lung cancer trial combines immunotherapy and targeted radiation
Disease control Not yet recruitingThis is a randomized trial evaluating the efficacy and safety of sequential dual-agent immunotherapy and risk-adapted radiotherapy for patients with locally advanced non-small cell lung cancer (NSCLC) with a PD-L1 tumor proportion score of at least 50%. Participants will be rando…
Phase: PHASE2 • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could a new drug beat the current standard for septic shock?
Disease control Not yet recruitingDespite best therapy efforts, sepsis and septic shock are associated with mortality rates of up to 40%. This clinical trial will determine the benefit of exogenous Angiotensin II versus norepinephrine (conventional care) treatment in septic shock patients. This trial will determi…
Phase: PHASE4 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can smart breathing devices save more cardiac arrest patients?
Disease control Not yet recruitingCardiac arrest is a life-threatening emergency that requires immediate treatment with cardiopulmonary resuscitation (CPR). While chest compressions circulate blood, manual ventilation provides oxygen to the patient. Current CPR guidelines recommend specific ventilation rates and …
Phase: NA • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New injection shows promise for Tough-to-Treat skin cancer
Disease control Recruiting nowOpen-label, single-arm, multicentre study in patients with locally advanced BCC amenable to intratumoral injection, who have progressed on or are intolerant to systemic therapy as determined by a local multidisciplinary tumor board. The primary objective of the study is to evalua…
Phase: PHASE2 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New Dual-Targeting cell therapy takes aim at Hard-to-Treat blood cancers
Disease control Not yet recruitingThis is a Phase 1 interventional, single-arm, open- label, treatment study designed to evaluate the safety of h20.19 CAR T cells in patients with B-cell malignancies that have failed prior therapies.
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Simple supplement may slow vision loss in rare eye disease
Disease control Not yet recruitingThe goal of this clinical trial is to look at the efficacy and safety of giving oral serine (an amino acid) on the progression of structural and functional changes of the retina in people with MacTel type 2. The main questions it aims to answer are: * Does serine slow the progre…
Phase: PHASE3 • Sponsor: The Lowy Medical Research Institute Limited • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Electric zaps to the gut could tame diabetes and fatty liver
Disease control Not yet recruitingThis study is designed to evaluate the efficacy, safety, and mechanisms of pulsENDO procedure in patients with T2DM and its effect on MASLD.
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
First human trial launches for brain cancer vaccine
Disease control Not yet recruitingThe objectives of this phase I first-in-human trial are to evaluate safety, feasibility, and preliminary efficacy of an individualized Bvax vaccine in addition to standard of care chemoradiation in patients with newly diagnosed glioblastoma.
Phase: PHASE1 • Sponsor: Catalina Lee Chang • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a single shot boost stroke recovery? new trial aims to find out
Disease control Not yet recruitingThis study is a prospective, multicenter, double-blind, randomized, placebo-controlled clinical trial designed to evaluate whether early administration of PCSK9 inhibitors can effectively improve functional outcomes at 90 days in patients with ischemic stroke (AIS) associated wit…
Phase: PHASE4 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New light treatment could fight oral cancer without surgery
Disease control Not yet recruitingThe primary goal of this study is to see if photodynamic therapy (PDT) is effective for treatment of lesions in the oral cavity which have high risk of becoming oral cancer. PDT treatment uses a drug, called a photosensitizer, which makes the diseased cells become light-sensitive…
Phase: PHASE2 • Sponsor: University of Massachusetts, Boston • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New pill may cut blood transfusions for kids with thalassemia
Disease control Not yet recruitingThe primary objective of this study is to compare the effect of mitapivat versus placebo on transfusion burden in pediatric participants with α- or β-transfusion-dependent thalassemia.
Phase: PHASE3 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Engineered immune cells take on brain cancer in early trial
Disease control TerminatedCentral nervous system lymphoma (CNSL) includes primary CNS lymphoma (PCNSL) and secondary CNS lymphoma (SCNSL), with diffuse large B-cell lymphoma as the predominant pathological type. Disease progression is often rapid and the relapse rate is high. Current standard treatment is…
Phase: PHASE1 • Sponsor: Beijing Boren Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Magic mushroom compound takes on PTSD in major new trial
Symptom relief Not yet recruitingThe Redefine Study (COMP202) is testing COMP360 to see if it may reduce post-traumatic stress disorder (PTSD) symptoms when administered alongside monitoring and support from a trained study team. COMP360 is a lab-made form of the naturally occurring chemical compound psilocybin.
Phase: PHASE2, PHASE3 • Sponsor: COMPASS Pathways • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New combo shows promise for Tough-to-Treat uterine cancer
Disease control Recruiting nowThe purpose of this study is to determine the efficacy and safety of Pembrolizumab in combination with Lenvatinib in recurrent, mismatch repair-proficient endometrial cancer after failure of first-line therapy with a platinum-based doublet chemotherapy and immunotherapy.
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New rehab program aims to protect cancer Survivors' hearts
Disease control Not yet recruitingCancer therapy-related cardiac dysfunction (CTRCD) has become a major cause of morbidity and mortality among cancer survivors. Although cardiac rehabilitation is recommended for cardiovascular disease prevention and management, high-quality randomized controlled evidence regardin…
Phase: NA • Sponsor: Xinjiang Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Breath of discovery: simple test may sniff out lung cancer
Diagnosis Not yet recruitingCryoPilot is a single-centre pilot study being conducted at Weston Park Cancer Centre in Sheffield, UK. The goal of this pilot study is to determine whether small-volume exhaled breath condensate sample (EBC) obtained via a VosCryo™ breath sample collection device can provide qua…
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust • Aim: Diagnosis
Last updated Jul 16, 2026 00:00 UTC
-
Could microplastics sabotage cancer treatment? new study investigates
Knowledge-focused Not yet recruitingMICRORAD is a pioneering 48-month translational research project that investigates the potential health and environmental impacts of micro- and nanoplastics (MNPs) released from medical devices when exposed to ionizing radiation. In radiation oncology, thermoplastic masks (TPMs) …
Sponsor: University of Kragujevac • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Ancient herbal mix could boost liver health in advanced cancer
Disease control Not yet recruitingPrimary liver cancer is a malignant tumor with a very poor prognosis. Hepatocellular carcinoma(HCC) accounts for approximately 80% of cases. Under the current targeted and immunotherapy-based treatment approaches, the overall survival of patients with advanced HCC has improved si…
Phase: PHASE2 • Sponsor: Xiang-Qian • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Kitchen cure: culinary medicine may help reverse metabolic syndrome
Disease control Not yet recruitingMetabolic syndrome is a major public health concern associated with an increased risk of cardiovascular disease, type 2 diabetes, and premature mortality. The Mediterranean diet has consistently demonstrated beneficial effects on metabolic health and is recommended as a dietary s…
Phase: NA • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Bedside flu shot for heart patients: a simple strategy to save lives?
Prevention Not yet recruitingThe aim of this study is to evaluate the effect of offering intrahospital influenza vaccination as an adjunct to active counseling during the index hospitalization to adult patients hospitalized for acute coronary syndrome (ACS) or congestive heart failure (CHF), compared with ac…
Phase: NA • Sponsor: Stephan Baldus • Aim: Prevention
Last updated Jul 25, 2026 00:00 UTC